Pyxis Oncology, Inc. (PYXS)
4.41
0.00 (0.00%)
USD |
NASDAQ |
Dec 12, 09:46
Pyxis Oncology Research and Development Expense (Quarterly): 17.35M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 2.436M |
| Pfizer Inc. | 2.492B |
| Ironwood Pharmaceuticals, Inc. | 21.99M |
| Akebia Therapeutics, Inc. | 14.63M |
| PTC Therapeutics, Inc. | 100.16M |